Acadia Stock Rallies On Big FDA Approval

ACAD stock is on track for its best day since Aug. 9

Managing Editor
Jun 29, 2018 at 9:57 AM
facebook twitter linkedin

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock is up 11.5% to trade at $16.80, after the Food and Drug Administration (FDA) approved new capsule dosing formulation and tablet strength for Nuplazid, the company's treatment for Parkinson's disease. ACAD is now pacing for its best day since Aug. 9. 

Today's surge runs counter to ACADIA Pharmaceuticals stock's longer-term trend. Heading into today's trading, the equity was down 50% as of yesterday's close. In fact, the shares have been lingering near four-year-low territory since a scathing CNN report on Nuplazid in early April. Plus, today's upside gap is being contained by familiar resistance at the 50-day moving average.

Nevertheless, analysts have kept the faith in the drugmaker. All four of the brokerages in coverage rate ACAD a "strong buy." What's more, the stock's average 12-month price target of $47.29 is a whopping 180% premium to the stock's current perch.

Short sellers, on the other hand, have been ramping up the skepticism on ACAD. Short interest increased by 20% in the most recent reporting period to 15.21 million shares, the most since September. This represents almost 16% of ACAD's total available float, and six times its average daily trading volume. Some of today's gains could be a result of the weaker bearish hands throwing in the towel.

Some of these shorts may have initiated options hedges to guard against any upside risk. The out-of-the-money July 18 call saw the largest increase in open interest during the last 10 sessions, and data from Trade-Alert points to buy-to-open activity.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 


300x250 - Banner 3 - v1